Aspire Biopharma Holdings, Inc.
NASDAQAspire Biopharma Holdings goes into its Monday earnings release with the borrow market completely exhausted — every share available to lend has already been borrowed, and the cost of doing so has hit its highest level in weeks. The borrow picture is extreme. Availability has fallen to 0%, meaning there is not a single share left in the lending pool relative to estimated short…
ASBP short interest collapses 99% in a week, falling to 17,639 shares as cost to borrow eases to 131% from 295%.
Snapshot as of 30 Jun 2026
Aspire Biopharma Holdings goes into its Monday earnings release with the borrow market completely exhausted — every share available to lend has already been borrowed, and the cost of doing so has hit its highest level…
Aspire Biopharma Holdings heads into its May 19 earnings report with one of the most expensive borrow markets on Nasdaq — a signal that the lending side of the trade is under real strain. The clearest indicator is the…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ASBP — free to start on ORTEX.
Sign up for free →Open ASBP on ORTEX